The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 30, 2018
Filed:
Jul. 03, 2014
Applicant:
Immunoqure Ag, Dusseldorf, DE;
Inventors:
Syeda F. Y. Haque, London, GB;
Adrian Hayday, Orpington, GB;
Kai Kisand, Tartu, EE;
Kai Krohn, Salmentaka, FI;
Annalisa Macagno, Schlieren, CH;
Steffen Meyer, Munich, DE;
Paert Peterson, Tallinn, EE;
Mike Rothe, Krailling, DE;
Philip Vlaicu, Alling, DE;
Martin Woodward, London, GB;
Assignee:
ImmunoQure AG, Martinsreid, DE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); C07H 21/04 (2006.01); G01N 33/564 (2006.01); G01N 33/68 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
C07K 16/249 (2013.01); A61K 47/48546 (2013.01); G01N 33/564 (2013.01); G01N 33/6866 (2013.01); C07K 2317/21 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/55 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/56 (2013.01);
Abstract
Provided are novel IFB-a binding molecules of human origin, particularly human-derived anti-IFN-α antibodies as well as IFN-α binding fragments, derivatives and variants thereof. In addition, pharmaceutical compositions, kits, and methods for use in diagnosis and therapy are described.